SLCT

MBX Biosciences Shares Debut Above IPO Price on Nasdaq MBX Biosciences (MBX) shares debuted on the Nasdaq Global Select Market Friday with an opening price of $23 apiece, above the initial public offering price of $16.The stock, trading under the ticker symbol "MBX," rose more than 42% in recent trading and was changing hands at $22.77 apiece.The initial public offering is set to close on Sept. 16.Price: 22.77, Change: +6.77, Percent Change: +42.31

时间:2024-09-14 01:18:29 市场: 美股 综合 期货

关联: NDAQ .IXIC MBX MBX.AU SLCT

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading European equities traded in the US as American depositary receipts were treading water late Thursday morning, nudging 0.1% lower to 1,424.33 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by internet browser company Opera (OPRA) and internet ad agency Criteo (CRTO), which rose 2.8% and 2%, respectively. They were followed by Sequans Communications S.A. (SQNS) and biopharmaceutical company Cellectis (CLLS), which were up 1.7% and 1.3%, respectively.The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biotech firm Evaxion Biotech (EVAX), which fell 6% and 3% respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company Grifols (GRFS), which were up 2.7% and 2.3%, respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm (TCBP) and cruise line operator Carnival

时间:2024-09-12 23:27:31 市场: 美股 综合

关联: CRTO SQNS EVAX SLCT AMRN